Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Seminars in Oncology

• Publication date

  1983-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.5555/URI:PII:0093775483900635PMID 6836326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.

  1982cited by this paper
• Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.

  1981cited by this paper
• Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.

  1981cited by this paper
• Effects of age and sex on microsomal heme oxygenase and cytochrome P-450 content in liver of rats.

  1981cited by this paper
• Role of aldehyde dehydrogenase in the metabolism-dependent biological activity of cyclophosphamide.

  1981cited by this paper
• Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide.

  1979cited by this paper
• Cyclophosphamide cystitis--identification of acrolein as the causative agent.

  1979cited by this paper
• Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.

  1979cited by this paper
• Studies on the binding of [3H-chloroethyl]-cyclophosphamide and 14[C-4] -cyclophosphamide to hepatic microsomes and native calf thymus DNA.

  1978cited by this paper
• Denaturation of cytochrome P-450 by cyclophosphamide metabolites.

  1978cited by this paper
• Donor pretreatment in cadaver renal transplantation.

  1977cited by this paper
• Characterization and quantitative estimation of activated cyclophosphamide in blood and urine.

  1977cited by this paper
• HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.

  1976cited by this paper
• Studies of the effects of cyclophosphamide, vincristine, and prednisone on some hepatic oxidations and conjugations.

  1976cited by this paper
• Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.

  1976cited by this paper
• Alkylating properties of phosphoramide mustard.

  1976cited by this paper
• Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite.

  1975cited by this paper
• Sex-dependent differences in drug metabolism in the rat. 3. Temporal changes in type I binding and NADPH-cytochrome, P-450 reductase during sexual maturation.

  1974cited by this paper
• Sex-dependent differences in drug metabolism in the rat. I. Temporal changes in microsomal drug-metabolizing system of the liver during sexual maturation.

  1974cited by this paper
• Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.

  1973cited by this paper
• Drug metabolism after repeated treatments with cytotoxic agents.

  1971cited by this paper
• The effect of cytotoxic agents on drug metabolism.

  1970cited by this paper
• Inhibition of hepatic microsomal enzymes by alkylating agents.

  1969cited by this paper
• Pharmacological implications of microsomal enzyme induction.

  1967cited by this paper
• Studies on the mechanism of action of cytoxan. Evidence of activation in vivo and in vitro.

  1961cited by this paper

• Experimental and Clinical Progress in Cancer Chemotherapy

  2011influential citation
• Increased Sensitivity of Glutathione S-Transferase P-Null Mice to Cyclophosphamide-Induced Urinary Bladder Toxicity

  2009cites this paper
• Acrolein health effects

  2008cites this paper
• Interaction ofN-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice

  2007cites this paper
• Toxicological profile for acrolein

  2007cites this paper
• Clinical Pharmacology of Cyclophosphamide and Ifosfamide

  2006cites this paper
• Reversal of resistance to oxazaphosphorines.

  2006cites this paper
• Metabolism and Transport of Oxazaphosphorines and the Clinical Implications

  2005cites this paper
• Cyclophosphamide, cisplatin, and carmustine: pharmacokinetics of carmustine following multiple alkylating-agent interactions

  2004cites this paper
• Mesna ameliorates intestinal mucosa damage after ifosfamide administration in the rabbit at a dose-related manner.

  2004cites this paper
• Impact of 30-Day Oral Dosing with N-acetyl-l-cysteine on Sprague-Dawley Rat Physiology

  2004cites this paper
• Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.

  2002cites this paper
• Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.

  2001cites this paper
• Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.

  2001cites this paper
• Effects of L‐2‐oxothiazolidine‐4‐carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases

  2000cites this paper
• Effects of dietary supplementation of N-acetylcysteine on cigarette smoke-related DNA adducts in rat tissues.

  1997cites this paper
• Uptake and distribution of N-acetylcysteine in mice: tissue-specific effects on glutathione concentrations.

  1995cites this paper
• Cyclophosphamide administered repeatedly to the male rat and as a single dose to the female rat. Its effects on hepatic and pulmonary P450 and associated enzymes.

  1995cites this paper
• Regulation of total ovarian glutathione content in the rat.

  1992cites this paper
• Use of N-acetylcysteine in clinical toxicology.

  1991cites this paper
• Mechanisms of in vitro immunosuppression by hepatocyte-generated cyclophosphamide metabolites and 4-hydroperoxycyclophosphamide.

  1990cites this paper
• Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols.

  1989cites this paper
• Studies on Hemotoxicity of Cyclophosphamide, Doxorubicin and Cis-Diamminodichloroplatinum Combined with Sodium-2-Mercaptoethane Sulfonate

  1988cites this paper
• The Role of Acetylcysteine in Clinical Toxicology

  1987cites this paper
• Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.

  1987cites this paper
• Immunomodulation exerted by cyclophosphamide is not interfered by N-acetyl cysteine.

  1986cites this paper
• Failure of N-acetylcysteine to protect against cis-dichlorodiammineplatinum(II)-induced hematopoietic toxicity in mice.

  1986cites this paper
• Carcinoma of the urinary bladder in patients receiving cyclophosphamide.

  1985cites this paper
• Metabolism-Dependent Toxicities of Cyclophosphamide and Protection by N-Acetylcysteine and Other Thiols

  1985cites this paper
• The effect of N-acetylcysteine on toxicity of cyclophosphamide and doxorubicin on murine hemopoietic progenitors.

  1985cites this paper
• The effect of penicillamine and related thiols on cyclophosphamide-induced cystitis and bone marrow suppression.

  1984cites this paper
• Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

  1984cites this paper
• Ifosfamide: chemotherapy with new promise and new problems for the urologist.

  1984cites this paper
• The action of anticlastogens in human lymphocyte cultures and its modification by rat liver S9 mix. I. Studies with AET and sodium fluoride.

  1984cites this paper
• Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.

  1984cites this paper